Andrew Muir
No más puestos en curso
Perfil
Andrew R.
Muir served as Chairman at Select Therapeutics, Inc. He was also a Director at Satcon Technology Corp.
from 2004 to 2007.
Additionally, he served as a Non-Executive Director at Christie Group Plc.
Dr. Muir holds a doctorate from the University of Oxford and an MBA from Pace University.
Antiguos cargos conocidos de Andrew Muir.
| Empresas | Cargo | Fin |
|---|---|---|
| SATCON TECHNOLOGY CORPORATION | Director/Miembro de la Junta | 20/12/2007 |
| CHRISTIE GROUP PLC | Director/Miembro de la Junta | 27/06/2005 |
Select Therapeutics, Inc.
 Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Presidente | - |
Formación de Andrew Muir.
| Pace University | Masters Business Admin |
| University of Oxford | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CHRISTIE GROUP PLC | Commercial Services |
| Empresas privadas | 2 |
|---|---|
Satcon Technology Corp.
 Satcon Technology Corp. SemiconductorsElectronic Technology Satcon Technology Corp. operates as a energy and power company. It provides system design services for utility-scale renewable energy plants. The firm designs and delivers advanced power conversion solutions that enable producers of renewable energy to convert clean energy into grid-connected and reliable electrical power. The company was founded by David B. Eisenhaure in February 1985 and is headquartered in Boston, MA. | Electronic Technology |
Select Therapeutics, Inc.
Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Muir
